News
Dementia is not a single disease — but rather a syndrome caused by various underlying conditions that damage the brain. The ...
Harvard's latest research has explored how your career choice may impact your memory function. Using death certificates from ...
Prof Sir John Hardy, Vice President of Alzheimer’s Research UK, outlines how the UK can drive progress towards a cure for ...
NewAmsterdam Pharma’s push to show a cholesterol drug can prevent Alzheimer’s disease has passed another test. | NewAmsterdam ...
Social interaction is part of adaptive functioning and should be promoted and encouraged. This helps reduce anxiety and ...
1h
News-Medical.Net on MSNLate-life mood disorders may signal neurodegenerative diseasesDepression and bipolar disorder of late onset may represent more than just mental health conditions. Growing evidence ...
The Scottish Medicines Consortium says there isn't enough evidence to prove how well donanemab treats dementia.
Widowed, divorced and never-married individuals in a US study had roughly 50 per cent or lower dementia risk compared with ...
Content by Health System. June is Alzheimer’s and Brain Awareness Month, which means there’s no better time to focus on your ...
4h
India Today on MSNDementia, Alzheimer's or just brain fog? Here's how to tell the differenceWhile dementia and brain fog can appear similar in some symptoms, they differ greatly in their underlying causes and nature.
Data collected by the association found for the first time, there are 7 million Americans living with the disease.
NewAmsterdam Pharma Announces Positive Topline Alzheimer’s Disease Data from BROADWAY Clinical Trial
Pre-specified analyses show that obicetrapib treatment leads to statistically significant and clinically meaningful reductions in the primary outcome measure of Alzheimer’s disease biomarker in both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results